<DOC>
	<DOCNO>NCT00346580</DOCNO>
	<brief_summary>Sepsis lead cause death critically ill patient United States . It develop approximately 750,000 Americans annually , 210,000 die . Despite improvement supportive treatment , mortality change little , recently , sepsis-specific treatment available . Protease inhibitor seem immune benefit extend beyond ability prevent HIV replication . T cell patient treat protease inhibitor reduce rate death patient receive therapy .</brief_summary>
	<brief_title>The Effects HIV Protease Inhibitors Severe Sepsis</brief_title>
	<detailed_description>Our hypothesis protease inhibitor therapy prevent apoptosis associate sepsis , manifest improved clinical outcome , assess 28-day mortality , APACHE II III , SOFA score . All patient enrol study receive standard care sepsis Mayo Clinic Rochester . Patients receive 1250 mg Nelfinavir/placebo twice day seven day regularly schedule blood draw ( Days 0 , 4 , 7 ) .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Infection criterion : know suspected infection , evidence one following : WBC normally sterile body fluid , radiographic evidence pneumonia , syndrome associate high risk infection . Modified SIRS criterion : must meet three follow four criterion : temperature high 38C low 36C , heart rate 90 beats/minute , respiratory rate 20 breaths/minute ( mechanical ventilator ) , WBC 12,000/mm ( 3 ) less 4,000/mm ( 3 ) . Dysfunctional organ criterion : must meet one follow five criterion : cardiovascular system dysfunction , kidney dysfunction , respiratory dysfunction , hematological dysfunction , unexplained metabolic acidosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>